ArticleCancer immunology, immunotherapy : CII2020

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models.

Rui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.